Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 31 -40 of 557 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis				Phase III				JCOG0504 C000000307, NCT00280475
	Pharmaco-Economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer				Phase III				I05026 NCT00284778
	Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)				Phase III				IFCT-0501 NCT00298415
	IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-Small Cell Lung Cancer				Phase III				2005.386 NCT00300586
	Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy				Phase III				SLCSG0501 NCT00300729
	Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery				Phase III				ECOG-E1505 E1505, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805
	Dietary Supplement in Treating Patients Who are Receiving Chemotherapy for Stage III or Stage IV Non-Small Cell Lung Cancer				Phase III				SFC-SV001 SFC-01-0150-0001-02-CM, SFC-01-0150-001, NCT00246727
	Selected Vegetables-Sun's Soup Dietary Supplement in Treating Patients Who Are Undergoing Supportive Care for Stage IIIB or Stage IV Non-Small Cell Lung Cancer				Phase III				SFC-SV002 NCT00246727
	Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Versus Adjuvant Chemotherapy in Early Stage NSCL				Phase III				CSLC0501 NCT00321334
	Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-Small Cell Lung Cancer				Phase III				2005-08-066 NCT00326378


					< Previous 1 2 3 4 5 6 7 Next >

| | | | | | | |

A Service of the National Cancer Institute